Press release article from our research archive:

Advice for patients on painkiller/anti-inflammatory - Celebrex.

M2 PRESSWIRE-21 December 2004-UK Government: Advice for patients on painkiller/anti-inflammatory - Celebrex(C)1994-2004 M2 COMMUNICATIONS LTD

RDATE:12212004

The Medicines and Healthcare products Regulatory Agency (MHRA) today issued new advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex.

Patients who are taking Celebrex, Bextra and Arcoxia should make a non-urgent appointment with their GP to review their treatment.

Patients who have established heart disease or who are at high risk of stroke will have their treatment changed. For all other patients, alternative treatments will be considered on the basis of their medical history.

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!